| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/25/2013 | WO2013057357A1 Method for identifying drugs of use in the treatment of cardiovascular diseases |
| 04/25/2013 | WO2013057313A1 Methods for the detection and the treatment of cardiac remodeling |
| 04/25/2013 | WO2013057188A1 In-bead screening |
| 04/25/2013 | WO2013057156A1 Grainyhead-like 1 gene and grainyhead-like 1 transcription factor for use in regulation of blood pressure in mammals |
| 04/25/2013 | WO2013057135A1 Troponin and bnp based diagnosis of risk patients and cause of stroke |
| 04/25/2013 | WO2013057096A1 Assessment of pml risk and methods based thereon |
| 04/25/2013 | WO2013057092A1 Methods of risk assessment of pml and related apparatus |
| 04/25/2013 | WO2013056841A1 A method for diagnosing tse |
| 04/25/2013 | WO2013056720A1 Fluorescent dyes with phosphorylated hydroxymethyl groups and their use in light microscopy and imaging techniques |
| 04/25/2013 | WO2013056377A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
| 04/25/2013 | WO2013056358A1 Method of determining risk of an acute cardiovascular event |
| 04/25/2013 | WO2013056307A1 Phytophthora phospholipase c |
| 04/25/2013 | WO2013036187A8 Determination of bacterial infections of the genus rickettsia and possibly borrelia, in patients exhibiting symptoms of disease and being blood donors |
| 04/25/2013 | WO2013033636A3 Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same |
| 04/25/2013 | WO2013033629A3 Methods and compositions for the treatment and diagnosis of colorectal cancer |
| 04/25/2013 | WO2013033459A3 Compositions, methods and uses for peptides in diagnosis, progression and treatment of cancers |
| 04/25/2013 | WO2013033383A3 Molecularly imprinted polymers for detection of contaminants |
| 04/25/2013 | WO2013033225A3 Voltage offset correction in high-throughput electrophysiological measurement system |
| 04/25/2013 | WO2013033074A3 Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use |
| 04/25/2013 | WO2013030578A3 Method for detecting nucleosomes |
| 04/25/2013 | WO2013028548A3 Compositions and devices for the detection of biomarkers in the gastrointestinal tract and methods for making and using them |
| 04/25/2013 | WO2013027986A3 Method of screening for chaperonin modulator |
| 04/25/2013 | WO2013025801A9 Control of biofouling in implantable biosensors |
| 04/25/2013 | WO2013017954A3 Tetrameric streptavidin mutein with reversible biotin binding capability |
| 04/25/2013 | WO2013016449A3 Assays for the detection of microbes |
| 04/25/2013 | WO2013012396A9 A method and apparatus for analyzing interactions of molecules |
| 04/25/2013 | WO2013009869A3 Akt-specific capture agents, compositions, and methods of using and making |
| 04/25/2013 | WO2013009146A3 Marker for diagnosing diabetic retinopathy |
| 04/25/2013 | WO2013003815A3 Near-infrared fluorescent dyes with large stokes shifts |
| 04/25/2013 | WO2012177656A3 Devices, solutions and methods for sample collection |
| 04/25/2013 | WO2012170880A3 Methods and apparatus for improving in vitro measurements using boyden chambers |
| 04/25/2013 | WO2012170478A3 Methods and kits for detecting adenomas, colorectal cancer, and uses thereof |
| 04/25/2013 | WO2012170078A3 Peptide capture and characterization |
| 04/25/2013 | WO2012162413A3 Methods and apparatuses for measuring tissue stiffness changes using ultrasound elasticity imaging |
| 04/25/2013 | WO2012151501A3 Apparatus for detecting tumor cells |
| 04/25/2013 | WO2012044987A8 Genetic modifiers of cystic fibrosis |
| 04/25/2013 | WO2012037928A3 Compounds for the diagnosis of neurodegenerative disorders on the olfactory epithelium |
| 04/25/2013 | WO2012025840A3 Apparatus and method for phase equilibrium with in-situ sensing |
| 04/25/2013 | WO2012016216A3 Assays for detection of glycosaminoglycans |
| 04/25/2013 | WO2011160042A3 Prpk-tprkb modulators and uses thereof |
| 04/25/2013 | WO2011116954A3 Prophylaxis of colorectal and gastrointestinal cancer |
| 04/25/2013 | WO2010116037A3 A screening method for haemoglobinopathies |
| 04/25/2013 | US20130103424 Microprocessor based glucose monitoring system |
| 04/25/2013 | US20130103336 Multi-modal data analysis for defect identification |
| 04/25/2013 | US20130102757 Methods for selective targeting |
| 04/25/2013 | US20130102544 Disease-Associated Proteins |
| 04/25/2013 | US20130102542 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets |
| 04/25/2013 | US20130102497 Assay for drug discovery based on in vitro differentiated cells |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |
| 04/25/2013 | US20130102494 Novel antibody for the diagnosis and/or prognosis of cancer |
| 04/25/2013 | US20130102491 Method for the diagnosis of tuberculosis |
| 04/25/2013 | US20130102489 Systems and methods for high-throughput detection of an analyte in a sample |
| 04/25/2013 | US20130102486 Perp as a prognostic and diagnostic marker for dysplasia and cancer |
| 04/25/2013 | US20130102482 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 04/25/2013 | US20130102081 Detection and Characterization of Protein Degradation, Protein Degradation Modulation and Protein Degradation Modulators |
| 04/25/2013 | US20130102063 Small molecules and protein analysis devices based on molecular imprinted polymers |
| 04/25/2013 | US20130102049 Removable saccharide-benzimidazole (bim) tags and conjugates thereof via 1h-position of the benzimidazoles |
| 04/25/2013 | US20130102020 Detection and Characterization of Protein Interactions, Protein Interaction Modulation and Protein Interaction Modulators |
| 04/25/2013 | US20130102015 Composition for the determination of coagulation characteristics of a test liquid |
| 04/25/2013 | US20130102013 Materials and methods to detect pyrimidine-pyrimidine dimer formation |
| 04/25/2013 | US20130102011 Human leucine-rich a-2-glycoprotein-1 and aminopeptidase n as risk indicators for cancer |
| 04/25/2013 | US20130102010 T1R Hetero-Oligomeric Taste Receptors and Cell Lines That Express Said Receptors and Use Thereof for Identification of Taste Compounds |
| 04/25/2013 | US20130102004 Endometrial Phase or Endometrial Cancer Biomarkers |
| 04/25/2013 | US20130102003 Point-of-Care Immunoassay for Quantitative Small Analyte Detection |
| 04/25/2013 | US20130101999 Multi-leg luminescent nanoparticles, multi-leg luminescent nanoparticle compounds and various applications |
| 04/25/2013 | US20130101998 Method for diagnosing kidney disease comprising detecting the level of annexin a2 or s100a6 |
| 04/25/2013 | US20130101992 Diagnostic Assay For Type 1 Diabetes |
| 04/25/2013 | US20130101989 Diagnostic Method for Predicting the Response of a Patient to Chemovirotherapy or Radiovirotherapy |
| 04/25/2013 | US20130101987 Detection of feline Immunodeficiency Virus |
| 04/25/2013 | US20130101985 Methods for the detection of jc polyoma virus |
| 04/25/2013 | US20130101984 Methods of detecting sleepiness |
| 04/25/2013 | US20130101611 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity |
| 04/25/2013 | US20130101606 Novel Phosphorylation of Cardiac Troponin I as a Monitor for Cardiac Injury |
| 04/25/2013 | US20130101605 Modulators and modulation of the interaction between rgm and neogenin |
| 04/25/2013 | US20130101600 Cxcl5 as a marker of hormone escape in prostate cancer |
| 04/25/2013 | US20130101599 Bcma-based stratification and therapy for multiple myeloma patients |
| 04/25/2013 | US20130101592 S100a4 antibodies and therapeutic uses thereof |
| 04/25/2013 | US20130101580 Compositions and methods for prolonging lifespan |
| 04/25/2013 | US20130101578 Biomarker for renal function in patients with type 2 diabetes |
| 04/25/2013 | US20130101523 Methods for detecting a mycobacterium tuberculosis infection |
| 04/25/2013 | US20130101519 Diagnostic Method for Atherosclerosis |
| 04/25/2013 | US20130101466 Cantilevered probe detector with piezoelectric element |
| 04/25/2013 | US20130100434 Optical detection apparatus and optical measurement system |
| 04/25/2013 | US20130099151 Particles |
| 04/25/2013 | US20130098844 Method and Arrangement for a Water Treatment Control |
| 04/25/2013 | US20130098775 Glucose biosensor with improved shelf life |
| 04/25/2013 | US20130098762 Patch-Clamp Providing On-Chip Thermal Gradient |
| 04/25/2013 | US20130098177 Apparatus for dissolution experiment of mineral |
| 04/25/2013 | US20130098176 Flat Laminate, Symmetrical Test Structures and Method of Use To Gauge White Bump Sensitivity |
| 04/25/2013 | US20130098141 Localized deposition of polymer film on nanocantilever chemical vapor sensors by surface-initiated atom transfer radical polymerization |
| 04/25/2013 | DE102011116440A1 Vorrichtung zum Messen von Parametern oder zur Probennahme in Eisen- oder Stahlschmelzen An apparatus for measuring parameters, or for sampling in iron or steel melts |
| 04/25/2013 | DE102011084957A1 Arrangement for monitoring oxygen concentration in processing device, has oxygen sensor positioned in processing device and is connected with monitoring circuit, which compares threshold value with output signal of oxygen sensor |
| 04/25/2013 | DE102011054334B4 Verfahren zur Bestimmung der Interaktion zwischen einem Polynucleotid und Blutplättchenfaktor 4 Method for determining the interaction between a polynucleotide and platelet factor 4 |
| 04/25/2013 | DE102010031528B4 System zur Bestimmung eines Energiegehalts eines festen Brennstoffs und Verwendung des Systems System for determining an energy content of a solid fuel and use of the system |
| 04/25/2013 | CA2853128A1 Functionalized nanoparticles for intracellular delivery of biologically active molecules |
| 04/25/2013 | CA2853103A1 Point-of-care immunoassay for quantitative small analyte detection |
| 04/25/2013 | CA2852954A1 Methods for improving inflammatory bowel disease diagnosis |
| 04/25/2013 | CA2852758A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
| 04/25/2013 | CA2852757A1 Predictive biomarkers for breast cancer |
| 04/25/2013 | CA2852733A1 Phytophthora phospholipase c |